Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DCTN3 antibody (AA 2-176)

This anti-DCTN3 antibody is a Rabbit Polyclonal antibody detecting DCTN3 in ELISA and IHC. Suitable for Human.
Catalog No. ABIN7615869

Quick Overview for DCTN3 antibody (AA 2-176) (ABIN7615869)

Target

See all DCTN3 (Dctn3) Antibodies
DCTN3 (Dctn3) (Dynactin 3 (p22) (Dctn3))

Reactivity

  • 21
  • 20
  • 17
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 33
  • 2
  • 1
Rabbit

Clonality

  • 35
  • 1
Polyclonal

Conjugate

  • 12
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This DCTN3 antibody is un-conjugated

Application

  • 23
  • 13
  • 13
  • 11
  • 6
  • 3
  • 3
  • 3
  • 1
  • 1
ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 15
    • 5
    • 3
    • 2
    • 1
    • 1
    AA 2-176

    Purpose

    Dctn3 Polyclonal Antibody

    Characteristics

    The Dctn3 Polyclonal Antibody (Species: Human) has been validated for the following applications: ELISA, IHC.

    Purification

    Protein G Purified

    Purity

    >95%

    Immunogen

    Recombinant Human Dynactin Subunit 3 Protein

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Preservative: 0.03 % Proclin 300, Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    DCTN3 (Dctn3) (Dynactin 3 (p22) (Dctn3))

    Alternative Name

    DCTN3

    UniProt

    O75935

    Pathways

    M Phase
You are here:
Chat with us!